Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics

Lilyana Amezcua; Flavia Nelson

doi:10.1007/s13311-017-0560-9

Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics

Lilyana Amezcua, Flavia Nelson

Neurology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.

Original language	English (US)
Pages (from-to)	945-951
Number of pages	7
Journal	Neurotherapeutics
Volume	14
Issue number	4
DOIs	https://doi.org/10.1007/s13311-017-0560-9
State	Published - Oct 1 2017

Keywords

Ethics
Multiple sclerosis
Patient-funded research

Access

10.1007/s13311-017-0560-9

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722765

Fingerprint Dive into the research topics of 'Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics'. Together they form a unique fingerprint.

Cite this

@article{5d05acccb1ed4eca8172fff3c2776b8e,

title = "Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics",

abstract = "Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.",

keywords = "Ethics, Multiple sclerosis, Patient-funded research",

author = "Lilyana Amezcua and Flavia Nelson",

year = "2017",

month = oct,

day = "1",

doi = "10.1007/s13311-017-0560-9",

language = "English (US)",

volume = "14",

pages = "945--951",

journal = "Neurotherapeutics",

issn = "1933-7213",

publisher = "Springer New York",

number = "4",

}

TY - JOUR

T1 - Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics

AU - Amezcua, Lilyana

AU - Nelson, Flavia

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.

AB - Patient-funded research has started to emerge in multiple sclerosis studies, such as low-dose naltrexone and stem-cell therapy. While these represent greater opportunities for the physician, scientist, and patient, ethical concerns concerning protocol review, conflict of interests, and protection of subjects are reviewed.

KW - Ethics

KW - Multiple sclerosis

KW - Patient-funded research

UR - http://www.scopus.com/inward/record.url?scp=85026818790&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026818790&partnerID=8YFLogxK

U2 - 10.1007/s13311-017-0560-9

DO - 10.1007/s13311-017-0560-9

M3 - Review article

C2 - 28779373

AN - SCOPUS:85026818790

VL - 14

SP - 945

EP - 951

JO - Neurotherapeutics

JF - Neurotherapeutics

SN - 1933-7213

IS - 4

ER -